248 related articles for article (PubMed ID: 15882724)
1. Differences between urologists in United States and Canada in approach to bladder cancer.
Chung D; Hersey K; Fleshner N
Urology; 2005 May; 65(5):919-25. PubMed ID: 15882724
[TBL] [Abstract][Full Text] [Related]
2. Differences between urologists in the United States and Canada in the approach to prostate cancer.
Fleshner N; Rakovitch E; Klotz L
J Urol; 2000 May; 163(5):1461-6. PubMed ID: 10751858
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis and treatment of bladder cancer.
Sharma S; Ksheersagar P; Sharma P
Am Fam Physician; 2009 Oct; 80(7):717-23. PubMed ID: 19817342
[TBL] [Abstract][Full Text] [Related]
4. 1999 American Urological Association Gallup Survey: changes in physician practice patterns, treatment of incontinence and bladder cancer, and impact of managed care.
O'Leary MP; Gee WF; Holtgrewe HL; Blute ML; Cooper TP; Miles BJ; Nellans RE; Thomas R; Painter MR; Meyer JJ; Naslund MJ; Gormley EA; Blizzard R; Fenninger RB
J Urol; 2000 Oct; 164(4):1311-6. PubMed ID: 10992396
[TBL] [Abstract][Full Text] [Related]
5. [Intravesical adjuvant chemotherapy for superficial bladder cancer -- results of a survey in Saxony].
Steinbach F; Schuster F
Aktuelle Urol; 2005 Aug; 36(4):337-41. PubMed ID: 16110407
[TBL] [Abstract][Full Text] [Related]
6. Smoking cessation assistance for patients with bladder cancer: a national survey of American urologists.
Bjurlin MA; Goble SM; Hollowell CM
J Urol; 2010 Nov; 184(5):1901-6. PubMed ID: 20846679
[TBL] [Abstract][Full Text] [Related]
7. Management of neurogenic bladder patients in The Netherlands: do urologists follow guidelines?
Rikken B; Blok BF
Neurourol Urodyn; 2008; 27(8):758-62. PubMed ID: 18508332
[TBL] [Abstract][Full Text] [Related]
8. Bladder and upper tract urothelial cancer.
Konety BR; Joyce GF; Wise M
J Urol; 2007 May; 177(5):1636-45. PubMed ID: 17437776
[TBL] [Abstract][Full Text] [Related]
9. Variation among pediatric urologists and across 2 continents in antibiotic prophylaxis and evaluation for prenatally detected hydronephrosis: a survey of American and European pediatric urologists.
Merguerian PA; Herz D; McQuiston L; Van Bibber M
J Urol; 2010 Oct; 184(4 Suppl):1710-5. PubMed ID: 20728177
[TBL] [Abstract][Full Text] [Related]
10. Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data Base.
David KA; Milowsky MI; Ritchey J; Carroll PR; Nanus DM
J Urol; 2007 Aug; 178(2):451-4. PubMed ID: 17561135
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.
Shariat SF; Karakiewicz PI; Palapattu GS; Lotan Y; Rogers CG; Amiel GE; Vazina A; Gupta A; Bastian PJ; Sagalowsky AI; Schoenberg MP; Lerner SP
J Urol; 2006 Dec; 176(6 Pt 1):2414-22; discussion 2422. PubMed ID: 17085118
[TBL] [Abstract][Full Text] [Related]
12. Adult anterior urethral strictures: a national practice patterns survey of board certified urologists in the United States.
Bullock TL; Brandes SB
J Urol; 2007 Feb; 177(2):685-90. PubMed ID: 17222657
[TBL] [Abstract][Full Text] [Related]
13. Chemo-prevention in superficial bladder cancer using mitomycin C: a survey of the practice patterns of British urologists.
Clarke NS; Basu S; Prescott S; Puri R
BJU Int; 2006 Apr; 97(4):716-9. PubMed ID: 16536760
[TBL] [Abstract][Full Text] [Related]
14. Partial cystectomy for muscle invasive urothelial carcinoma of the bladder: a contemporary review of the M. D. Anderson Cancer Center experience.
Kassouf W; Swanson D; Kamat AM; Leibovici D; Siefker-Radtke A; Munsell MF; Grossman HB; Dinney CP
J Urol; 2006 Jun; 175(6):2058-62. PubMed ID: 16697803
[TBL] [Abstract][Full Text] [Related]
15. Impact of superficial bladder cancer and transurethral resection on general health-related quality of life: an SF-36 survey.
Yoshimura K; Utsunomiya N; Ichioka K; Matsui Y; Terai A; Arai Y
Urology; 2005 Feb; 65(2):290-4. PubMed ID: 15708040
[TBL] [Abstract][Full Text] [Related]
16. Bladder cancer.
Gwynn ES; Clark PE
Curr Opin Oncol; 2006 May; 18(3):277-83. PubMed ID: 16552241
[TBL] [Abstract][Full Text] [Related]
17. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.
Yu RJ; Stein JP; Cai J; Miranda G; Groshen S; Skinner DG
J Urol; 2006 Aug; 176(2):493-8; discussion 498-9. PubMed ID: 16813876
[TBL] [Abstract][Full Text] [Related]
18. Current practice in the management of superficial bladder cancer in the Netherlands and Belgian Flanders: a survey.
Witjes JA; Melissen DO; Kiemeney LA
Eur Urol; 2006 Mar; 49(3):478-84. PubMed ID: 16406242
[TBL] [Abstract][Full Text] [Related]
19. Upper tract urothelial recurrence following radical cystectomy for transitional cell carcinoma of the bladder: an analysis of 1,069 patients with 10-year followup.
Sanderson KM; Cai J; Miranda G; Skinner DG; Stein JP
J Urol; 2007 Jun; 177(6):2088-94. PubMed ID: 17509294
[TBL] [Abstract][Full Text] [Related]
20. Understanding bladder cancer death: tumor biology versus physician practice.
Morris DS; Weizer AZ; Ye Z; Dunn RL; Montie JE; Hollenbeck BK
Cancer; 2009 Mar; 115(5):1011-20. PubMed ID: 19152434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
